antiviral drug News
Most Popular antiviral drug Story
Investors disappointed in Vertex despite strong data
Vertex shares sank on Friday after the company reported that its closely-watched hepatitis C drug telaprevir eradicated the virus in more than 60 percent of patients. Standard therapies on the market Read more...
Latest Headlines
- November 5, 2007
- June 24, 2007
- December 12, 2006
- February 15, 2006
- January 30, 2006
- December 21, 2005
- November 15, 2005
- October 30, 2005
- October 26, 2005
- October 25, 2005
- October 20, 2005
- October 19, 2005
- October 17, 2005
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
